AGL250117P17500
- 12.30
- 0.000.00%
Agilon Health Newsroom
Goldman Sachs Maintains Agilon Health(AGL.US) With Hold Rating, Announces Target Price $2.5
Worst Performing Stocks for Tax Loss Selling – Wolfe
Forecasting The Future: 10 Analyst Projections For Agilon Health
Macquarie Initiates Agilon Health(AGL.US) With Hold Rating, Announces Target Price $3
Agilon Health Initiated at Neutral by Macquarie
Agilon Health Price Target Announced at $3.00/Share by Macquarie
Investors Still Aren't Entirely Convinced By Agilon Health, Inc.'s (NYSE:AGL) Revenues Despite 42% Price Jump
Bernstein Initiates Agilon Health(AGL.US) With Hold Rating, Announces Target Price $2.5
Express News | Agilon Health Inc : Bernstein Initiates Coverage With Market Perform Rating; Target Price $2.50
Does Agilon Health (NYSE:AGL) Have A Healthy Balance Sheet?
Agilon Health to Present Growth Plans at Conference
RBC Capital Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $3
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $4
Express News | Agilon Health Inc : Benchmark Cuts Target Price to $3
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Citi Maintains Agilon Health(AGL.US) With Sell Rating, Cuts Target Price to $1.75
Agilon Health Shares Are Trading Lower After Stifel Cut Its Price Target on the Stock From $7 to $2.
Agilon Health Reports ACO REACH Model Results for 2023 Performance Year
Express News | Agilon Health Reports Aco Reach Model Results for 2023 Performance Year